학술논문
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
Document Type
Article
Author
Source
In: Neuro-Oncology Advances . (Neuro-Oncology Advances, 1 January 2021, 3(1))
Subject
Language
English
ISSN
26322498